CN107320133B - Urinary incontinence treatment apparatus - Google Patents
Urinary incontinence treatment apparatus Download PDFInfo
- Publication number
- CN107320133B CN107320133B CN201710690995.2A CN201710690995A CN107320133B CN 107320133 B CN107320133 B CN 107320133B CN 201710690995 A CN201710690995 A CN 201710690995A CN 107320133 B CN107320133 B CN 107320133B
- Authority
- CN
- China
- Prior art keywords
- patient
- urinary incontinence
- ultrasonic
- treatment apparatus
- pelvic floor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 68
- 206010046543 Urinary incontinence Diseases 0.000 title claims abstract description 51
- 210000003205 muscle Anatomy 0.000 claims abstract description 41
- 210000003903 pelvic floor Anatomy 0.000 claims abstract description 38
- 238000002604 ultrasonography Methods 0.000 claims abstract description 30
- 210000001217 buttock Anatomy 0.000 claims abstract description 4
- 230000033001 locomotion Effects 0.000 claims description 11
- 239000000523 sample Substances 0.000 claims description 6
- 230000008602 contraction Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 22
- 210000001519 tissue Anatomy 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 238000010792 warming Methods 0.000 abstract description 3
- 230000008859 change Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 13
- 239000003814 drug Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000005284 excitation Effects 0.000 description 6
- 206010066218 Stress Urinary Incontinence Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 4
- 208000022170 stress incontinence Diseases 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 210000005070 sphincter Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000001981 hip bone Anatomy 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- ZLSOONVQLWLPMF-UHFFFAOYSA-M 3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium;dibromide Chemical compound [Br-].[Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 ZLSOONVQLWLPMF-UHFFFAOYSA-M 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- XIQVNETUBQGFHX-UHFFFAOYSA-N Ditropan Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCC#CCN(CC)CC)C1CCCCC1 XIQVNETUBQGFHX-UHFFFAOYSA-N 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 239000000048 adrenergic agonist Substances 0.000 description 1
- 229940126157 adrenergic receptor agonist Drugs 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000110 cooling liquid Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 229960002102 imipramine hydrochloride Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960005434 oxybutynin Drugs 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Detecting organic movements or changes, e.g. tumours, cysts, swellings
- A61B8/0833—Detecting organic movements or changes, e.g. tumours, cysts, swellings involving detecting or locating foreign bodies or organic structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
- A61N7/022—Localised ultrasound hyperthermia intracavitary
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Percussion Or Vibration Massage (AREA)
- Electrotherapy Devices (AREA)
Abstract
The present application relates to a urinary incontinence treatment apparatus, comprising: a patient carrier (4) for a patient to be positioned thereon for treatment; and an ultrasonic emitter (5) provided on the patient carrying part (4), when the patient is positioned on the patient carrying part (4), the buttocks of the patient are seated on the ultrasonic emitter (5) so that the ultrasonic emitted by the ultrasonic emitter (5) acts on the pelvic floor muscles of the patient. By applying the technical scheme of the application, the urinary incontinence treatment equipment mainly stimulates pelvic floor muscles of a patient by utilizing the warming effect, cavitation effect and mechanical effect of ultrasound, so that the change beneficial to restoring the functions of the pelvic floor muscles is generated in tissues of the pelvic floor muscles, and the effect of improving the condition of urinary incontinence is achieved.
Description
Technical Field
The application relates to the field of medical equipment, in particular to urinary incontinence treatment equipment.
Background
Along with the progress of the development technology of society, people have more clear knowledge about the disease of urinary incontinence, and along with this, various methods for treating urinary incontinence are also presented, and currently, the main methods for treating urinary incontinence are pelvic floor muscle exercise, medication, surgical treatment and the like.
Pelvic floor muscle exercise: the pelvic floor muscle exercise method is very simple, can be carried out by means of special instruments or without any instruments, and can be carried out in any occasion and time without being perceived by people. The method comprises the following steps: the vagina and anus are contracted, lifted, relaxed after 2-3 seconds, and then the previous actions are repeated. This exercise is performed 300 to 500 times per day. These actions need not be done once, can be done in several times, generally lasting at least 1-2 months to be effective, and need to last for more than one year, require a fairly long treatment period even with specialized equipment, and have a certain effect only on light stress incontinence.
Drug treatment: adrenergic receptor agonists (e.g., guan, ephedrine) are the most commonly used drugs for treating stress incontinence, and are also the drugs currently being studied to be the most effective drugs for treating stress incontinence by increasing the occlusive ability of the urethral sphincter. Some cases may be treated with anticholinergic drugs, for example: propidium bromide, imipramine and oxybutynin hydrochloride. Estrogens can be used to treat stress urinary incontinence in postmenopausal women. Estrogens have the effect of increasing the tension and blood supply of the urethral sphincter, but the efficacy is still controversial. In addition, patients with stress incontinence, such as breast cancer, cervical cancer, and uterine cancer, should not receive estrogen medication. The secondary treatment method has large limitation, usually does not cure the root cause, and has high recurrence rate.
Surgical treatment: the method for surgical treatment comprises the following steps: post urethral injection of sclerosant, various suspension procedures, artificial urethral sphincter insertion procedures, urethral extension or folding procedures, and the like. The internationally established treatment regimen is via tension-free vaginal sling implantation (TVT implantation). The operation is to put a sling made of special polypropylene material into the body, and when the intra-abdominal pressure is increased, the sling can be lifted relatively to press the urethra, so that urine leakage is inhibited. Although the treatment method is minimally invasive, certain pains and risks exist.
The application of ultrasound is very wide and has also been greatly developed in medicine, including ultrasound diagnosis and ultrasound therapy. Therapeutic ultrasound can be further classified into High-Intensity focused ultrasound (High Intensity FocusUltrasound, HIFU) and low-Intensity pulsed ultrasound (Low Intensity Pulsed Ultrasound, LIPU). The high-intensity focused ultrasonic wave is used as a new non-invasive tumor treatment technology, is increasingly widely applied to clinical application, and is applied to the treatment of prostate cancer, pancreatic cancer, liver cancer, hysteromyoma and the like at present. The low-intensity pulse ultrasonic wave mainly utilizes the warm effect, cavitation effect and mechanical effect of ultrasonic wave to stimulate human tissues, so that beneficial, usually reversible, changes are generated in the human tissues, thereby promoting the wound healing of the tissues or exciting certain cells to restore normal functions. Researchers have performed a number of animal and human experiments that verify the therapeutic effects of LIPU on different tissues of the human body, including: promoting wound healing, tendon repair, bone joint injury repair, nerve repair and regeneration; it also has effects in promoting local blood circulation of pathological tissue, and promoting metabolism.
Disclosure of Invention
The present application aims to provide a urinary incontinence treatment apparatus to improve the treatment effect on urinary incontinence.
According to one aspect of an embodiment of the present application, there is provided a urinary incontinence treatment apparatus comprising:
a patient carrier for a patient to be positioned thereon for treatment; and
and the ultrasonic transmitter is arranged on the patient bearing part, and when the patient is positioned on the patient bearing part, the buttocks of the patient are seated on the ultrasonic transmitter, so that ultrasonic waves emitted by the ultrasonic transmitter act on pelvic floor muscles of the patient.
Optionally, the tip of the ultrasound emitter protrudes from the patient carrier.
Optionally, the ultrasound emitter is movable in a direction perpendicular to the patient carrier.
Optionally, the ultrasound emitter is movable along the patient carrier.
Optionally, the urinary incontinence treatment apparatus further comprises a pressure sensor coupled to the ultrasonic emitter for detecting the contractile pressure of the pelvic floor muscle of the patient.
Optionally, the urinary incontinence treatment apparatus further comprises:
a first moving part for driving the ultrasonic transmitter to move along a direction perpendicular to the patient carrying part; and
and the second moving part is used for driving the first moving part to move along the patient bearing part.
Optionally, the patient carrier comprises a chair.
Optionally, the urinary incontinence treatment apparatus further comprises:
a processor for controlling the start and stop of the ultrasonic transmitter, the movement of the ultrasonic transmitter and/or the frequency of ultrasonic waves emitted by the ultrasonic transmitter; and
and the display is connected with the processor and used for displaying the working information of the urinary incontinence treatment equipment.
Optionally, the operational information includes a position of the ultrasound emitter relative to the patient support, a frequency of ultrasound emitted by the ultrasound emitter, or a treatment time.
By applying the technical scheme of the application, the urinary incontinence treatment equipment mainly stimulates pelvic floor muscles of a patient by utilizing the warming effect, cavitation effect and mechanical effect of ultrasound, so that the change beneficial to restoring the functions of the pelvic floor muscles is generated in tissues of the pelvic floor muscles, and the effect of improving the condition of urinary incontinence is achieved.
Other features of the present application and its advantages will become apparent from the following detailed description of exemplary embodiments of the application, which proceeds with reference to the accompanying drawings.
Drawings
In order to more clearly illustrate the embodiments of the application or the technical solutions of the prior art, the drawings which are used in the description of the embodiments or the prior art will be briefly described, it being obvious that the drawings in the description below are only some embodiments of the application, and that other drawings can be obtained according to these drawings without inventive faculty for a person skilled in the art.
FIG. 1 shows a schematic configuration of a main body of a urinary incontinence treatment apparatus of an embodiment of the application;
FIG. 2 shows a schematic structural view of a patient-carrying member of a urinary incontinence treatment apparatus of an embodiment of the application;
FIG. 3 shows a schematic structural view of the interior of a patient-carrying member of a urinary incontinence treatment apparatus of an embodiment of the application; and
fig. 4. A circuit diagram of a urinary incontinence treatment apparatus of an embodiment of the application is shown.
In the figure: 1. a case; 2. a display; 3. a pulley; 4. a patient carrier; 5. an ultrasonic emitter; 6. a first moving member; 7. a second moving member; 8. a pressure sensor; 9. and (5) a mounting seat.
Detailed Description
The following description of the embodiments of the present application will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present application, but not all embodiments. The following description of at least one exemplary embodiment is merely exemplary in nature and is in no way intended to limit the application, its application, or uses. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
Fig. 1 shows a schematic structural view of a carriage of the urinary incontinence treatment apparatus of the present embodiment. Fig. 2 shows a schematic structural view of a patient-carrying portion of the urinary incontinence treatment apparatus of this embodiment.
The urinary incontinence treatment apparatus of this embodiment includes an excitation source for generating an electric pulse and an ultrasonic transmitter 5 capable of generating ultrasonic waves under excitation of the electric pulse. The ultrasonic transmitter 5 includes a housing and a piezoelectric wafer disposed within the housing. The piezoelectric wafer vibrates under the excitation of the electric pulse, thereby forming ultrasonic waves. The trolley is provided with a box body 1, and the excitation source is arranged in the box body 1. The trolley further comprises a pulley 3 arranged below the box.
The excitation source comprises an ultrasonic main board and a power supply for providing electric energy for the ultrasonic main board. Optionally, the power supply is a switching power supply. The ultrasonic main board is provided with a circuit for forming electric pulses.
The ultrasonic main board of the excitation source is connected with the ultrasonic transmitter 5 through a radio frequency cable, so that the electric pulse formed by the ultrasonic main board excites the piezoelectric wafer of the ultrasonic transmitter 5.
In this embodiment, the ultrasonic wave emitted by the ultrasonic wave emitter 5 may be any type of ultrasonic wave, and preferably, the ultrasonic wave is a low-intensity pulsed ultrasonic wave. The frequency of the ultrasonic wave is 1-2MHz, and preferably the frequency of the ultrasonic wave is 1.5-1.7MHz.
The sound intensity of the ultrasonic wave is 0.05-3w/cm 2 . Preferably, the intensity of the ultrasonic wave is in the range of 0.1-0.5w/cm 2 . Preferably the ultrasonic wave has a sound intensity in the range of 0.3-0.4w/cm 2 。
The urinary incontinence treatment apparatus of this embodiment further comprises a cooling liquid storage member for cooling the ultrasonic emitter 5. Of course, the urinary incontinence treatment apparatus may also be a cooled liquid storage member that does not include the above.
Fig. 2 shows a schematic structural view of the patient support 4 of the present embodiment. Fig. 3 shows a schematic structural view of the inside of the patient support 4 of the present embodiment. As shown in fig. 2 and 3, the ultrasonic emitter 5 is provided on the patient support 4, and when the patient is positioned on the patient support 4, the buttocks of the patient are seated on the ultrasonic emitter 5 so that the ultrasonic waves emitted by the ultrasonic emitter 5 act on the pelvic floor muscles of the patient.
In this embodiment, the patient support 4 comprises a chair.
In this embodiment, the urinary incontinence treatment apparatus mainly stimulates pelvic floor muscles of a human body by using the warming effect, cavitation effect and mechanical effect of ultrasound, so that changes beneficial to restoring functions of the pelvic floor muscles are generated in tissues of the pelvic floor muscles, thereby achieving the effect of treating urinary incontinence.
In this embodiment, the tip of the ultrasonic emitter 5 protrudes from the patient support 4 to apply pressure to the pelvic floor muscles of the patient to cause the pelvic floor muscles of the patient to contract, thereby achieving the effect of exercising the pelvic floor muscles of the patient.
The ultrasonic emitter 5 is reciprocally movable in a direction perpendicular to the patient support 4 to repeatedly apply pressure to the pelvic floor muscles of the patient to cause the pelvic floor muscles of the patient to contract.
The urinary incontinence treatment apparatus further comprises a first movement member 6 for driving the ultrasonic emitter 5 in a direction perpendicular to the patient carrier 4 to adjust the pressure applied by the ultrasonic emitter 5 to the pelvic floor muscles of the patient. In the present embodiment, the first moving member 6 is a linear moving member. Optionally, the linear motion member comprises an electric push rod.
The ultrasound transmitter 5 is movable along a bearing surface of the patient bearing part 4 for bearing a patient in order to adjust the position of the ultrasound transmitter 5 relative to the patient.
The urinary incontinence treatment apparatus further comprises a second movement member 7 for moving the ultrasound emitter 5 along the bearing surface of the patient bearing 4. The first moving member 6 is mounted on the second moving member 7 to move with the second moving member 7.
As shown in fig. 3, the urinary incontinence treatment apparatus further comprises a mounting seat 9 for mounting the second moving member 7. The mount 9 is fixed relative to the patient support 4. The second moving member 7 is movable relative to the mount 9.
The second moving part 7 comprises a sliding base. The urinary incontinence treatment apparatus further comprises a motor for driving the movement of the sliding base and a transmission connecting the motor with the second movement member 7.
In this embodiment, the motor driving the sliding base to move is a stepper motor.
The urinary incontinence treatment apparatus further comprises a microcontroller for controlling the movement of the first and second moving members 6, 7 to adjust the height and position of the ultrasound transducer 5 relative to the patient carrier 4.
The microcontroller is connected with the electric push rod and the motor for driving the second moving part 7 to move.
Alternatively, the transmission means connecting the motor and the second moving part 7 comprise a screw, a slider in threaded engagement with the screw and a motor for driving the screw in rotation. In the process of rotating the screw, the sliding block moves along the screw. The sliding base is connected with the sliding block so that the sliding base can move along the screw rod along with the sliding block.
In this embodiment, a pressure sensor 8 is also included, connected to the ultrasound transmitter 5, for detecting the systolic pressure of the pelvic floor muscles of the patient.
The urinary incontinence treatment apparatus further comprises an industrial personal computer, the industrial personal computer comprising:
a processor for controlling the start and stop of the ultrasonic emitter 5, the movement and/or the frequency of the ultrasonic waves emitted by the ultrasonic emitter 5; and
and the display 2 is connected with the processor and used for displaying the working information of the urinary incontinence treatment equipment.
The operational information includes the position of the ultrasound emitter 5 relative to the patient support, the frequency of the ultrasound emitted by the ultrasound emitter 5, or the treatment time.
Fig. 4 shows a circuit diagram of the urinary incontinence treatment apparatus of this embodiment. As shown in fig. 4, the urinary incontinence treatment apparatus of this embodiment includes a microcontroller, which also supplies power to the wiring. The power supply lines are provided with output sockets or pins for connecting to an external power supply network. And a switch is also arranged on the power supply line and used for controlling the on-off of the power supply line and an external power supply network.
The industrial personal computer and the power supply for supplying power to the ultrasonic main board are respectively connected with a power supply circuit. The urinary incontinence treatment apparatus further comprises an industrial personal computer adapter connected between the power supply line and the industrial personal computer, the industrial personal computer adapter being used for converting the voltage of the power supply line into a voltage required by the industrial personal computer.
The microcontroller for controlling the first moving part 6 and the second moving part 7 is also connected to the above-mentioned power supply for powering the ultrasound motherboard.
In this embodiment, a pressure sensor 8 for detecting the pelvic floor muscle contraction pressure of the patient is connected to the microcontroller to feed back the detected pressure information to the microcontroller. The microcontroller is connected with the processor of the industrial personal computer so that the industrial personal computer can detect the pressure information detected by the pressure sensor, and the industrial personal computer can also control the first moving part 6 and the second moving part 7 through the microcontroller.
When a patient is treated with the urinary incontinence treatment apparatus of this embodiment:
first, the doctor tells the patient about the specific location of the pelvic floor muscles. The treatment probe mainly composed of the ultrasonic emitter 5 on the chair can be protruded out of the chair and can move back and forth, so that the patient can be helped to accurately identify the pelvic floor muscles.
The patient then applies a pressure of about 10kg to the patient's basin muscles by adjusting the height of the treatment probe, and then turns on the ultrasound transmitter 5 to begin operation. When the ultrasonic transmitter is contacted with the human body along with the lifting of the treatment probe, the ultrasonic wave starts to act on the human body.
The pelvic floor muscles will then contract to oppose the pressure applied to them by the treatment probe, and the patient will feel the pelvic floor muscles pressurized by the body pressure and consciously contract the pelvic floor muscles. When the patient contracts the pelvic floor muscle, the muscles between the hip bones become tight and thick, and then the force between the hip bones pushes the pressure sensor 8 downward, so that the pressure sensor 8 can know how much contraction force the patient uses.
The urinary incontinence treatment apparatus of this embodiment has a variety of built-in pelvic muscle training procedures, and when the patient selects one procedure, the desired pressure and the actual pressure applied by the patient to the pelvic muscle are displayed in real time on a display and a chart is formed. Therefore, a patient can learn how to perform treatment by looking at the display, and can perform pelvic floor muscle training and ultrasonic treatment simultaneously by the instrument without inserting a probe into the vagina, so that embarrassment is avoided as much as possible, the risk of bringing pathogens into the vagina is avoided, the treatment mode has more obvious curative effect, and the treatment period is shortened compared with the simple pelvic floor muscle training.
The beneficial effects of the application are as follows: the ultrasonic urinary incontinence treatment device is simple and convenient to operate and complete in function, can enable a patient to effectively treat according to a treatment plan formulated by a doctor, shortens the treatment period compared with simple pelvic floor muscle training, remarkably improves the treatment effect, reduces the pain of the patient, and is automatically controlled by software, so that the workload of medical staff is greatly reduced.
The foregoing is illustrative of the present application and is not to be construed as limiting thereof, but rather, any modification, equivalent replacement, improvement or the like which comes within the spirit and principles of the present application are intended to be included within the scope of the present application.
Claims (8)
1. A urinary incontinence treatment apparatus, comprising:
a patient carrier (4) for a patient to be positioned thereon for treatment; and
an ultrasonic emitter (5) arranged on the patient carrying part (4), when the patient is positioned on the patient carrying part (4), the buttocks of the patient are seated on the ultrasonic emitter (5) so that the ultrasonic emitted by the ultrasonic emitter (5) acts on the pelvic floor muscles of the patient,
the ultrasonic transmitter (5) can reciprocate along the direction perpendicular to the patient bearing part (4) so as to repeatedly apply pressure to the pelvic floor muscles of the patient to promote the contraction of the pelvic floor muscles of the patient, the patient bearing part (4) comprises a chair, and a treatment probe mainly composed of the ultrasonic transmitter (5) on the chair can be protruded out of the chair and can move back and forth so as to help the patient to identify the pelvic floor muscles.
2. Urinary incontinence treatment apparatus according to claim 1, characterized in that the tip of the ultrasonic emitter (5) protrudes from the patient carrier (4).
3. Urinary incontinence treatment apparatus according to claim 1, characterized in that the ultrasonic emitter (5) is movable in a direction perpendicular to the patient carrier (4).
4. Urinary incontinence treatment apparatus according to claim 1, characterized in that the ultrasound transmitter (5) is movable along the patient carrier (4).
5. Urinary incontinence treatment apparatus according to claim 1, characterized in that it also comprises a pressure sensor (8) connected to the ultrasonic transmitter (5) for detecting the contraction pressure of the pelvic floor muscles of the patient.
6. The urinary incontinence treatment apparatus of claim 1, further comprising:
a first moving part (6) for driving the ultrasonic emitter (5) to move in a direction perpendicular to the patient support (4); and
-a second movement member (7) for moving the first movement member (6) along the patient carrier (4).
7. The urinary incontinence treatment apparatus of claim 1, further comprising:
a processor for controlling the start and stop, movement of the ultrasonic emitter (5) and/or the frequency of the ultrasonic waves emitted by the ultrasonic emitter (5); and
and the display (2) is connected with the processor and used for displaying the working information of the urinary incontinence treatment equipment.
8. Urinary incontinence treatment apparatus according to claim 7, characterized in that the working information comprises the position of the ultrasound transmitter (5) with respect to the patient carrier (4), the frequency of the ultrasound transmitted by the ultrasound transmitter (5), or the treatment time.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2016106819491 | 2016-08-17 | ||
| CN201610681949 | 2016-08-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107320133A CN107320133A (en) | 2017-11-07 |
| CN107320133B true CN107320133B (en) | 2023-11-21 |
Family
ID=60225678
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201721010342.7U Active CN209236201U (en) | 2016-08-17 | 2017-08-14 | Urinary incontinence treatment apparatus |
| CN201710690995.2A Active CN107320133B (en) | 2016-08-17 | 2017-08-14 | Urinary incontinence treatment apparatus |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201721010342.7U Active CN209236201U (en) | 2016-08-17 | 2017-08-14 | Urinary incontinence treatment apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN209236201U (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN209236201U (en) * | 2016-08-17 | 2019-08-13 | 北京万孛力医疗器械有限公司 | Urinary incontinence treatment apparatus |
| EP3815741A4 (en) | 2018-06-29 | 2022-03-30 | Teijin Pharma Limited | Chair-type phototherapy device |
| CN112700856A (en) * | 2021-01-15 | 2021-04-23 | 南京微医智能医药科技有限公司 | Integrated application device for pelvic floor muscles and control method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520844A (en) * | 2012-07-03 | 2014-01-22 | 重庆海扶医疗科技股份有限公司 | Focused ultrasonic treating device |
| CN203619570U (en) * | 2013-11-15 | 2014-06-04 | 北京君仪凯医疗科技有限公司 | Rehabilitation treatment device for vaginal contractions |
| CN104869902A (en) * | 2012-12-18 | 2015-08-26 | 莫库比技术有限公司 | Biofeedback apparatus using magnetic stimulator, and control method therefor |
| CN105310693A (en) * | 2014-06-30 | 2016-02-10 | 陈青越 | Wireless Kegel exercise training device |
| CN209236201U (en) * | 2016-08-17 | 2019-08-13 | 北京万孛力医疗器械有限公司 | Urinary incontinence treatment apparatus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040049240A1 (en) * | 2002-09-06 | 2004-03-11 | Martin Gerber | Electrical and/or magnetic stimulation therapy for the treatment of prostatitis and prostatodynia |
| US20070027511A1 (en) * | 2005-08-01 | 2007-02-01 | Ty Fairneny | Collagen injection combined with focused ultrasound for the treatment of incontinence |
| US9283385B2 (en) * | 2013-11-15 | 2016-03-15 | Uk Do-I Co., Ltd. | Seating apparatus for diagnosis and treatment of diagnosing and curing urinary incontinence, erectile dysfunction and defecation disorders |
-
2017
- 2017-08-14 CN CN201721010342.7U patent/CN209236201U/en active Active
- 2017-08-14 CN CN201710690995.2A patent/CN107320133B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520844A (en) * | 2012-07-03 | 2014-01-22 | 重庆海扶医疗科技股份有限公司 | Focused ultrasonic treating device |
| CN104869902A (en) * | 2012-12-18 | 2015-08-26 | 莫库比技术有限公司 | Biofeedback apparatus using magnetic stimulator, and control method therefor |
| CN203619570U (en) * | 2013-11-15 | 2014-06-04 | 北京君仪凯医疗科技有限公司 | Rehabilitation treatment device for vaginal contractions |
| CN105310693A (en) * | 2014-06-30 | 2016-02-10 | 陈青越 | Wireless Kegel exercise training device |
| CN209236201U (en) * | 2016-08-17 | 2019-08-13 | 北京万孛力医疗器械有限公司 | Urinary incontinence treatment apparatus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107320133A (en) | 2017-11-07 |
| CN209236201U (en) | 2019-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10245439B1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US10709894B2 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US20200384282A1 (en) | High power time varying magnetic field therapy | |
| JP6772061B2 (en) | Light emitting diodes and massage devices for home vaginal reactivation | |
| Alizadeh et al. | Review of the mechanisms and effects of noninvasive body contouring devices on cellulite and subcutaneous fat | |
| US10569095B1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| US10695575B1 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| CN1980610B (en) | Electromagnetic treatment apparatus | |
| US8043234B2 (en) | System and method for providing therapeutic treatment using a combination of ultrasound, electro-stimulation and vibrational stimulation | |
| US20220000509A1 (en) | Ultrasound Device for Use with Synthetic Cavitation Nuclei | |
| EP1110532B1 (en) | Slimming device | |
| US20190192872A1 (en) | Aesthetic Method of Biological Structure Treatment by Magnetic Field | |
| CN107320133B (en) | Urinary incontinence treatment apparatus | |
| US20090005710A1 (en) | Ultrasonic Equipment for Treatment of Osteoarthritis | |
| CN101443074A (en) | Integrated coil device and method for using the same | |
| KR20050009991A (en) | Procedure and machine for electro-inducing/stimulating deep-layered muscle contractions using a biphasic faradic pulse sequence | |
| US11534619B2 (en) | Aesthetic method of biological structure treatment by magnetic field | |
| CN101160152A (en) | Electromagnetic treatment induction apparatus and method for using same | |
| KR20210150798A (en) | Pulsed electromagnetic field pain controller | |
| CN108096704B (en) | Device and system for treating infertility and method for carrying out body fluid regulation and nerve channel regulation | |
| CN116370822A (en) | System applied to abdominal basin muscle function recovery and application method thereof | |
| KR20150060644A (en) | High Intensity Focused Ultrasonic Medical Instrument | |
| CA2442047A1 (en) | Method of treating osteochondrosis and apparatus for treating osteochondrosis | |
| Darwich et al. | Revolutionizing Spinal Care: 3D Printing a Customized Ultrasound-Reinforced Orthosis for Scoliosis Treatment | |
| CN211178929U (en) | Energy testing device for laser penetration of laser therapeutic instrument to focus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |